Search for Clinical Trial Results

Sponsored By

Premenstrual Dysphoric Disorder - 20 Studies Found

Status Study
Recruiting Study Name: Alternative Treatments for Premenstrual Dysphoric Disorder
Condition: Premenstrual Dysphoric Disorder
Date: 2013-02-25
Interventions:
  • Other: LWT+AM BWL One night of
Active, not recruiting Study Name: Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study
Condition: Premenstrual Dysphoric Disorder
Date: 2015-07-22
Interventions:
  • Drug: Oxytocin Intranasal Oxyt
Completed Study Name: YAZ Premenstrual Dysphoric Disorder (PMDD) in China
Condition: Premenstrual Dysphoric Disorder ( PMDD)
Date: 2009-01-15
Interventions:
  • Drug: EE20/DRSP(YAZ, BAY86-5300)

Completed Study Name: Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
Condition: Premenstrual Dysphoric Disorder
Date: 2007-08-16
Interventions: Drug: Levetiracetam Levetiracetam was started at 250 mg qhs at the end of the first week of the follicul
Not yet recruiting Study Name: Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
Condition: Premenstrual Dysphoric Disorder
Date: 2010-10-07
Interventions:
  • Drug: PH80 PH80 intranasal spr
Not yet recruiting Study Name: Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD)
Condition: Premenstrual Dysphoric Disorder
Date: 2015-05-03
Interventions:
  • Device: dTMS H-coil system:magstim stimulator rapid2,BrainswayH1coil

Completed Study Name: Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)
Condition: Premenstrual Dysphoric Disorder
Date: 2009-06-22
Interventions:
  • Drug: Continuous OC (EE/DROS)

Completed Study Name: A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)
Condition: Premenstrual Dysphoric Disorder
Date: 2013-05-29
Interventions:
  • Drug: UC1010
  • Drug: Placebo
Completed Study Name: Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
Condition: Premenstrual Dysphoric Disorder
Date: 2007-09-25
Interventions:
  • Drug: Sertraline 50 mg of sert
Completed Study Name: The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder
Condition:
  • Premenstrual Dysphoric Disorder
  • Premenstrual Syndrome
    • Date: 2008-05-13
    Interventions: Drug: fluoxetine Fluoxetine 20 mg daily by mouth for 2-3 months.
Next >>>